Biogen
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1978-01-01
- Employees
- 7.5K
- Market Cap
- $29.6B
- Website
- https://www.biogen.com
- Introduction
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMAD...
A Study to Find Out How Litifilimab is Processed in the Body in Healthy Participants When Given Under the Skin in 3 Different Ways
- Conditions
- Interventions
- First Posted Date
- 2024-12-19
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Biogen
- Target Recruit Count
- 236
- Registration Number
- NCT06741657
A Study to Find Out How Different Forms of BIIB091 is Processed in The Body With and Without Food in Healthy Participants
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Biogen
- Target Recruit Count
- 24
- Registration Number
- NCT06640933
- Locations
- 🇺🇸
PPD Las Vegas Research Unit, Las Vegas, Nevada, United States
🇺🇸PPD Clinical Research Unit, Austin, Texas, United States
A Study to Learn How BIIB141 (Omaveloxolone) Affects the Health of Participants With Friedrich's Ataxia Who Took it During Pregnancy and/or During Breastfeeding and About the Health of Their Babies
- First Posted Date
- 2024-10-08
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Biogen
- Target Recruit Count
- 20
- Registration Number
- NCT06628687
- Locations
- 🇺🇸
Evidera, Morrisville, North Carolina, United States
A Study to Find Out How Multiple Doses of BIIB091 Affect the Electrical Activity of the Heart in Healthy Participants
- Conditions
- Interventions
- First Posted Date
- 2024-08-28
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Biogen
- Target Recruit Count
- 64
- Registration Number
- NCT06574828
- Locations
- 🇺🇸
Austin Clinic PPD, Austin, Texas, United States
A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
- Conditions
- Interventions
- First Posted Date
- 2024-08-15
- Last Posted Date
- 2024-08-15
- Lead Sponsor
- Biogen
- Target Recruit Count
- 55
- Registration Number
- NCT06555419
A Study to Determine the Biodistribution, Safety, and Tolerability of a Microdose of Radiolabeled BIIB080 Co-administered With BIIB080 in Healthy Adults
- Conditions
- Interventions
- First Posted Date
- 2024-06-12
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- Biogen
- Target Recruit Count
- 5
- Registration Number
- NCT06454721
- Locations
- 🇺🇸
UC Davis, Sacramento, California, United States
A Study to Look at How a Single Oral Dose of Carbon-14-Labelled [14C] BIIB091 Moves Through and is Processed by the Body in Healthy Male Participants
- First Posted Date
- 2024-03-15
- Last Posted Date
- 2024-05-23
- Lead Sponsor
- Biogen
- Target Recruit Count
- 8
- Registration Number
- NCT06311786
- Locations
- 🇺🇸
PPD Clinical Research Unit, Austin, Texas, United States
A Study to Assess the Potential for Gastric-pH Dependent Drug-Drug Interactions of BIIB122 With a Proton Pump Inhibitor in Healthy Participants
- First Posted Date
- 2024-02-20
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Biogen
- Target Recruit Count
- 18
- Registration Number
- NCT06264440
- Locations
- 🇺🇸
PPD Development, LP, Austin, Texas, United States
A Study to Evaluate the Pharmacokinetics, Safety and Immunogenicity of BIIB800 Subcutaneously (SC) Compared to Actemra® in Healthy Male Participants
- First Posted Date
- 2024-02-16
- Last Posted Date
- 2024-12-12
- Lead Sponsor
- Biogen
- Target Recruit Count
- 300
- Registration Number
- NCT06262477
- Locations
- 🇬🇧
Fortrea Clinical Research Unit Inc., Leeds, West Yorkshire, United Kingdom
A Study to Assess New Participant's Perspectives Beyond Clinical Efficacy of Monoclonal Antibody-Based Relapsing Remitting Multiple Sclerosis (RRMS) Treatments
- Conditions
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2024-12-18
- Lead Sponsor
- Biogen
- Target Recruit Count
- 474
- Registration Number
- NCT06127095
- Locations
- 🇺🇸
Biogen, Cambridge, Massachusetts, United States